Insider Trading Alert - BDSI, LDRH And LNKD Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 16, 2014, 105 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $63.36 to $15,595,781.10.

Highlighted Stocks Traded by Insiders:

BioDelivery Sciences International (BDSI) - FREE Research Report

Sirgo Mark A, who is President and CEO at BioDelivery Sciences International, bought 2,500 shares at $12.23 on Dec. 16, 2014. Following this transaction, the President and CEO owned 923,602 shares meaning that the stake was boosted by 0.27% with the 2,500-share transaction.

The shares most recently traded at $12.65, up $0.42, or 3.32% since the insider transaction. Historical insider transactions for BioDelivery Sciences International go as follows:

  • 4-Week # shares bought: 2,000
  • 4-Week # shares sold: 7,853
  • 12-Week # shares bought: 2,000
  • 12-Week # shares sold: 7,853
  • 24-Week # shares bought: 3,800
  • 24-Week # shares sold: 97,239

The average volume for BioDelivery Sciences International has been 849,900 shares per day over the past 30 days. BioDelivery Sciences International has a market cap of $708.8 million and is part of the health care sector and drugs industry. Shares are up 108.74% year-to-date as of the close of trading on Monday.

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, develops and commercializes therapeutics in the areas of pain management and oncology supportive care. Currently, there are 4 analysts who rate BioDelivery Sciences International a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on BDSI - FREE

TheStreet Quant Ratings rates BioDelivery Sciences International as a sell. Among the areas we feel are negative, one of the most important has been generally deteriorating net income. Get the full BioDelivery Sciences International Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

LDR (LDRH) - FREE Research Report

Lavigne Christophe, who is President & CEO at LDR, sold 25,000 shares at $31.64 on Dec. 16, 2014. Following this transaction, the President & CEO owned 883,827 shares meaning that the stake was reduced by 2.75% with the 25,000-share transaction.

The shares most recently traded at $31.33, down $0.31, or 0.99% since the insider transaction. Historical insider transactions for LDR go as follows:

  • 4-Week # shares bought: 110,000
  • 4-Week # shares sold: 25,000
  • 12-Week # shares bought: 110,000
  • 12-Week # shares sold: 358,075
  • 24-Week # shares bought: 110,000
  • 24-Week # shares sold: 419,890

The average volume for LDR has been 251,800 shares per day over the past 30 days. LDR has a market cap of $832.5 million and is part of the health care sector and health services industry. Shares are up 33.35% year-to-date as of the close of trading on Monday.

LDR Holding Corporation designs, manufactures, and markets surgical implants, devices, and instrumentation for the treatment of spine disorders in the United States, France, and internationally. Currently, there are 2 analysts who rate LDR a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LDRH - FREE

TheStreet Quant Ratings rates LDR as a sell. The area that we feel has been the company's primary weakness has been its poor profit margins. Get the full LDR Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

LinkedIn (LNKD) - FREE Research Report

Sze David L, who is Director at LinkedIn, sold 1,500 shares at $220.45 on Dec. 16, 2014. Following this transaction, the Director owned 54,938 shares meaning that the stake was reduced by 2.66% with the 1,500-share transaction.

The shares most recently traded at $215.57, down $4.88, or 2.26% since the insider transaction. Historical insider transactions for LinkedIn go as follows:

  • 4-Week # shares sold: 1,500
  • 12-Week # shares sold: 23,369
  • 24-Week # shares sold: 66,301

The average volume for LinkedIn has been 1.7 million shares per day over the past 30 days. LinkedIn has a market cap of $23.8 billion and is part of the technology sector and internet industry. Shares are up 0.55% year-to-date as of the close of trading on Monday.

LinkedIn Corporation operates an online professional network. Currently, there are 18 analysts who rate LinkedIn a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LNKD - FREE

TheStreet Quant Ratings rates LinkedIn as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and a generally disappointing performance in the stock itself. Get the full LinkedIn Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Stocks Are Lower as Dow Heads for Eighth Straight Drop

Stocks Are Lower as Dow Heads for Eighth Straight Drop

Video: Here's Why One Markets Pro Is Raising Cash Right Now

Video: Here's Why One Markets Pro Is Raising Cash Right Now

Mesoblast Soars on Stem-Cell Treatment Data

Mesoblast Soars on Stem-Cell Treatment Data

Trade Tussle Sinks Stocks, Oil Slides, Micron, Daimler - 5 Things You Must Know

Trade Tussle Sinks Stocks, Oil Slides, Micron, Daimler - 5 Things You Must Know

Bank of England Holds Rates Steady, But Vote Shift Signals Hawkish Tone

Bank of England Holds Rates Steady, But Vote Shift Signals Hawkish Tone